This activity is supported by an independent medical educational grant from Sandoz Inc., a Novartis Company.

Best Practices in the Management of Infectious Complications for Patients with Cancer

James S. Lewis II, PharmD, FIDSA
Oregon Health and Science University

Immune suppression increases the risk for developing infection and/or sepsis. As antibiotic resistant bacteria are becoming ubiquitous, managing infection becomes more complex. Optimizing preventive measures, early diagnosis and management of infection is of the highest priority in cancer care. This educational activity will enable advanced practitioners to hone their skills in risk assessment, recognition and early intervention in the management of infection, optimizing treatment in the era of antibiotic-resistant bacteria, and understand the role of biosimilars and their reference G-CSFs in the prophylaxis and treatment of febrile neutropenia.



 

Download Podcast

   To claim credit for podcast click here
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

   To claim credit for the slides & transcript click here





These CE/CME/CEU accredited activities are jointly provided by

JADPRO Logo    Harborside Press Logo    APSHO Logo    Annenberg Logo
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me